These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2453565)

  • 1. Kinetics of MHC-antigen complex formation on antigen-presenting cells.
    Roosnek E; Demotz S; Corradin G; Lanzavecchia A
    J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time dependence of B cell processing and presentation of peptide and native protein antigens.
    Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
    J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.
    Ashwell JD; Jenkins MK; Schwartz RH
    J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
    Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
    Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationization of protein antigens. IV. Increased antigen uptake by antigen-presenting cells.
    Apple RJ; Domen PL; Muckerheide A; Michael JG
    J Immunol; 1988 May; 140(10):3290-5. PubMed ID: 3258879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C; Umetsu D; Schneeberger E; Geha RS
    J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences among various lineages of antigen-presenting cells in processing exogenous antigen internalized through transferrin receptors.
    McCoy KL; Page MS; Merkel BJ; Inman JK; Stutzman R
    J Immunol; 1993 Dec; 151(12):6757-68. PubMed ID: 7903098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
    Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging early steps of human T cell activation by antigen-presenting cells.
    Donnadieu E; Cefai D; Tan YP; Paresys G; Bismuth G; Trautmann A
    J Immunol; 1992 May; 148(9):2643-53. PubMed ID: 1349319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell clones present antigen.
    Hewitt CR; Feldmann M
    J Immunol; 1989 Jul; 143(2):762-9. PubMed ID: 2472452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.